Telomir Pharma - TELO Net Assets per Single Share

Graphic logo of Telomir Pharmaceuticals (TELO)

Risks for Telomir Pharmaceuticals (TELO) are linked to its dependence on the success of clinical trials and the patent protection of small molecules. The book value per share visualizes these fluctuations, where 0.07 determines the current status of the parameter. Stability is provided by its status as an innovator in cellular rejuvenation and its independence from macroeconomic cycles, which makes the company's assets recession-resistant.

Telomir Pharmaceuticals Inc (TELO): Share Book Value from 02/21/2024 to 10/28/2026

telomirpharma.com - analytical breakdowns and key metrics (TELO)

- price and consensus price forecast:
Price Chart Telomir Pharma|TELO - Price Target Chart
- market capitalization data:
Market Value Telomir Pharmaceuticals, Inc.|TELO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Telomir Pharmaceuticals|TELO - Net Asset Value|Market Capitalization to Book Value Ratio telomirpharma.com|TELO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Telomir Pharmaceuticals|TELO - Long-Term Debt to Capital|Short-Term Debt to Equity Telomir Pharmaceuticals, Inc.|TELO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Telomir Pharmaceuticals, Inc.|TELO - Company Long-Term Liabilities|Company Short-Term Debts Telomir Pharmaceuticals
Fundamental company valuation:Telomir Pharma - TELO
Manufactured products of Telomir Pharmaceuticals, Inc.

To minimize investment risks, it is essential to assess the actual net asset value, particularly in capital-intensive projects focused on creating a longevity ecosystem and developing telomeric drugs for Telomir Pharmaceuticals (TELO). The current book value trend reflects the remaining equity after all debts are settled, allowing the investor to see the true material foundation of the business beyond market speculation.

Competitors of Telomir Pharmaceuticals (TELO)

HLN - Net Assets per Single Share|KVUE: Net Assets per Single Share|Net Assets per Single Share VRNA|MENS (jyongbio.com) - Net Asset Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|MindWalk Holdings (HYFT) - Net Assets per Single Share|Accounting Value of a Share abvcpharma.com ABVC|Accounting Value per Share Cumberland Pharmaceuticals Inc. (CPIX)|Book Price of a Share Quantum BioPharma Ltd. QNTM|FGEN (FibroGen Corp) - Book Value per Share|RANI: Net Asset Value per Share|synergychc.com (SNYR) - Net Assets per Single Share|RLYB (Rallybio) - Net Assets per Single Share|Net Assets per Single Share LEXX (Lexaria Bioscience Corp)|Net Asset Value per Share PULM|Net Assets per Single Share PTHL (Pheton Holdings Ltd)|Accounting Value per Share aptorumgroup.com (APM)|Book Value per Share LYRA|Impact BioMedical, Inc. - Net Assets per Share|Net Assets per Single Share TNF Pharma (TNFA)|cbdMD, Inc. (YCBD) - Accounting Value of a Share|Accounting Value per Share PainReform Limited PRFX|CYTO (Altamira Therapeutics Ltd.) - Accounting Value of a Share|Net Assets per Single Share Lipella Pharmaceuticals LIPO|Share Book Value optinose.com|Pieris Pharmaceuticals, Inc. (PIRS) - Book Value per Share|Accounting Value of a Share Procaps Group (PROC)|Book Value per Share PTPI (Petros)|Qilian International Corp - Book Value per Share|Net Assets per Single Share Acelyrin, Inc. (SLRN)|TFFP: Accounting Value of a Share